Cargando…

Genetic variants within the hTERT gene and the risk of colorectal cancer in Lynch syndrome

Lynch syndrome is an inherited cancer-predisposing disorder caused by germline mutations in the DNA mismatch repair (MMR) genes but there is a high degree of variability in cancer risk observed among carriers, suggesting the existence of modifying factors. Our aim was to investigate variants within...

Descripción completa

Detalles Bibliográficos
Autores principales: Win, Aung Ko, Clendenning, Mark, Crawford, William, Rosty, Christophe, Preston, Susan G., Southey, Melissa C., Parry, Susan, Giles, Graham G., Macrae, Finlay A., Winship, Ingrid M., Baron, John A., Hopper, John L., Jenkins, Mark A., Buchanan, Daniel D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4701223/
https://www.ncbi.nlm.nih.gov/pubmed/26807197
_version_ 1782408438732554240
author Win, Aung Ko
Clendenning, Mark
Crawford, William
Rosty, Christophe
Preston, Susan G.
Southey, Melissa C.
Parry, Susan
Giles, Graham G.
Macrae, Finlay A.
Winship, Ingrid M.
Baron, John A.
Hopper, John L.
Jenkins, Mark A.
Buchanan, Daniel D.
author_facet Win, Aung Ko
Clendenning, Mark
Crawford, William
Rosty, Christophe
Preston, Susan G.
Southey, Melissa C.
Parry, Susan
Giles, Graham G.
Macrae, Finlay A.
Winship, Ingrid M.
Baron, John A.
Hopper, John L.
Jenkins, Mark A.
Buchanan, Daniel D.
author_sort Win, Aung Ko
collection PubMed
description Lynch syndrome is an inherited cancer-predisposing disorder caused by germline mutations in the DNA mismatch repair (MMR) genes but there is a high degree of variability in cancer risk observed among carriers, suggesting the existence of modifying factors. Our aim was to investigate variants within the hTERT gene as a potential colorectal cancer (CRC) risk modifier for MMR gene mutation carriers. We identified 1098 MMR gene mutation carriers (420 MLH1, 481 MSH2, 126 MSH6, 53 PMS2 and 18 EPCAM) from 330 families recruited from either family cancer clinics or population cancer registries of the Australasian Colorectal Cancer Family Registry between 1997 and 2012. Using weighted Cox regression after adjusting for ascertainment bias, we estimated associations between 23 SNPs within the hTERT gene and CRC risk. During 46,836 person-years observation, 392 (36%) carriers were diagnosed with CRC at a mean age of 42.2 (standard deviation 11.4) years. There was no evidence of association between any of the hTERT SNPs and CRC risk, overall and stratified by sex and MMR gene mutated, after adjustment for multiple testing. Our findings suggest no evidence for clinical utility of the SNPs within the hTERT gene in Lynch syndrome.
format Online
Article
Text
id pubmed-4701223
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Impact Journals LLC
record_format MEDLINE/PubMed
spelling pubmed-47012232016-01-22 Genetic variants within the hTERT gene and the risk of colorectal cancer in Lynch syndrome Win, Aung Ko Clendenning, Mark Crawford, William Rosty, Christophe Preston, Susan G. Southey, Melissa C. Parry, Susan Giles, Graham G. Macrae, Finlay A. Winship, Ingrid M. Baron, John A. Hopper, John L. Jenkins, Mark A. Buchanan, Daniel D. Genes Cancer Review Lynch syndrome is an inherited cancer-predisposing disorder caused by germline mutations in the DNA mismatch repair (MMR) genes but there is a high degree of variability in cancer risk observed among carriers, suggesting the existence of modifying factors. Our aim was to investigate variants within the hTERT gene as a potential colorectal cancer (CRC) risk modifier for MMR gene mutation carriers. We identified 1098 MMR gene mutation carriers (420 MLH1, 481 MSH2, 126 MSH6, 53 PMS2 and 18 EPCAM) from 330 families recruited from either family cancer clinics or population cancer registries of the Australasian Colorectal Cancer Family Registry between 1997 and 2012. Using weighted Cox regression after adjusting for ascertainment bias, we estimated associations between 23 SNPs within the hTERT gene and CRC risk. During 46,836 person-years observation, 392 (36%) carriers were diagnosed with CRC at a mean age of 42.2 (standard deviation 11.4) years. There was no evidence of association between any of the hTERT SNPs and CRC risk, overall and stratified by sex and MMR gene mutated, after adjustment for multiple testing. Our findings suggest no evidence for clinical utility of the SNPs within the hTERT gene in Lynch syndrome. Impact Journals LLC 2015-11 /pmc/articles/PMC4701223/ /pubmed/26807197 Text en Copyright: © 2015 Win et al. http://creativecommons.org/licenses/by/2.5/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Review
Win, Aung Ko
Clendenning, Mark
Crawford, William
Rosty, Christophe
Preston, Susan G.
Southey, Melissa C.
Parry, Susan
Giles, Graham G.
Macrae, Finlay A.
Winship, Ingrid M.
Baron, John A.
Hopper, John L.
Jenkins, Mark A.
Buchanan, Daniel D.
Genetic variants within the hTERT gene and the risk of colorectal cancer in Lynch syndrome
title Genetic variants within the hTERT gene and the risk of colorectal cancer in Lynch syndrome
title_full Genetic variants within the hTERT gene and the risk of colorectal cancer in Lynch syndrome
title_fullStr Genetic variants within the hTERT gene and the risk of colorectal cancer in Lynch syndrome
title_full_unstemmed Genetic variants within the hTERT gene and the risk of colorectal cancer in Lynch syndrome
title_short Genetic variants within the hTERT gene and the risk of colorectal cancer in Lynch syndrome
title_sort genetic variants within the htert gene and the risk of colorectal cancer in lynch syndrome
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4701223/
https://www.ncbi.nlm.nih.gov/pubmed/26807197
work_keys_str_mv AT winaungko geneticvariantswithinthehtertgeneandtheriskofcolorectalcancerinlynchsyndrome
AT clendenningmark geneticvariantswithinthehtertgeneandtheriskofcolorectalcancerinlynchsyndrome
AT crawfordwilliam geneticvariantswithinthehtertgeneandtheriskofcolorectalcancerinlynchsyndrome
AT rostychristophe geneticvariantswithinthehtertgeneandtheriskofcolorectalcancerinlynchsyndrome
AT prestonsusang geneticvariantswithinthehtertgeneandtheriskofcolorectalcancerinlynchsyndrome
AT southeymelissac geneticvariantswithinthehtertgeneandtheriskofcolorectalcancerinlynchsyndrome
AT parrysusan geneticvariantswithinthehtertgeneandtheriskofcolorectalcancerinlynchsyndrome
AT gilesgrahamg geneticvariantswithinthehtertgeneandtheriskofcolorectalcancerinlynchsyndrome
AT macraefinlaya geneticvariantswithinthehtertgeneandtheriskofcolorectalcancerinlynchsyndrome
AT winshipingridm geneticvariantswithinthehtertgeneandtheriskofcolorectalcancerinlynchsyndrome
AT baronjohna geneticvariantswithinthehtertgeneandtheriskofcolorectalcancerinlynchsyndrome
AT hopperjohnl geneticvariantswithinthehtertgeneandtheriskofcolorectalcancerinlynchsyndrome
AT jenkinsmarka geneticvariantswithinthehtertgeneandtheriskofcolorectalcancerinlynchsyndrome
AT buchanandanield geneticvariantswithinthehtertgeneandtheriskofcolorectalcancerinlynchsyndrome